References
- DeMario MD, Ratain MJ. Oral chemotherapy: rationale and future directions. J Clin Oncol 1998; 16 (7): 2557–2567.
- Skirvin JA, Lichtman SM. Pharmacokinetic considera-tions of oral chemotherapy in elderly patients with cancer. Drugs Aging 2002; 19 (1): 25–42.
- Comis RL, Friedland DM, Good BC. The role of oral etoposide in non-small cell lung cancer. Drugs 1999; 58 (suppl 3): 21-30.
- Simon R. Optimal two-stages for phase II clinical trials. Control Clin Trials 1989; 10 (1): 1–10.
- Gentili D, Zucchetti M, Torn V, et al. A limited sampling model for the pharmacokinetics of etoposide given orally. Cancer Chemother Pharmacol 1993; 32 (6): 482–486.
- Robieux I, Aita P, Sorio R, Toffoli G, Boiocchi M. Determination of unbound etoposide concentration in ultrafil-tered plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Biomed Appl 1996; 686 (1): 35–41.
- Toffoli G, Corona G, Sorio R, et al. Population pharma-cokinetics and pharmacodynamics of oral etoposide. Br J Clin Pharmacol 2001; 52 (5): 511–519.
- Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Blackwell Sc. Publ. (Oxford). 1987: 129-132.
- Repetto L, Fratino L, Audisio RA et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002; 20 (2): 494–502.
- Zagonel V, Pinto A, Serraino D et al. Lung cancer in the elderly. Cancer Treat Rev 1994; 20: 315–329.
- Gridelli C, Maione P, Barletta E. Individualized chemotherapy for elderly patients with non small cell lung can-cer. Curr Opin Oncol 2002; 14 (2): 199–203.
- Gridelli C, Shepherd FA. Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evi-dence. Chest 2005; 128 (2): 947–957.
- Carney DN. The pharmacology of intravenous and oral etoposide. Cancer 1991; 67 (1): 299–302.
- Joel SP, Shah R, Clark PI, Slevin ML. Predicting etoposide toxicity: relationship to organ function and protein binding. J Clin Oncol 1996; 14 (1): 257–267.
- Balducci L, Yates J. General guidelines for the manage-ment of older patients with cancer. Oncology (Huntington) 2000; 14 (11A): 221-227.
- Huisman C, Smit EF, Giaccone G, Postmus PE. Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review. J Clin Oncol 2000; 18 (21): 3722–3730.